The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
Open accessAbstract
The melanocortin-4 receptor (MC4R) is well recognized as an important mediator of body weight homeostasis. Activation of MC4R causes dramatic weight loss in rodent models, and mutations in human are associated with obesity. This makes MC4R a logical target for pharmacological therapy for the treatment of obesity. However, previous studies in rodents and humans have observed a broad array of side effects caused by acute treatment with MC4R agonists, including increased heart rate and blood pressure. We demonstrate that treatment with a highly-selective novel MC4R agonist (BIM-22493 or RM-493) resulted in transient decreases in food intake (35%), with persistent weight loss over 8 weeks of treatment (13.5%) in a diet-induced obese nonhuman primate model. Consistent with weight loss, these animals significantly decreased adiposity and improved glucose tolerance. Importantly, we observed no increases in blood pressure or heart rate with BIM-22493 treatment. In contrast, treatment with LY2112688, an MC4R agonist previously shown to increase blood pressure and heart rate in humans, caused increases in blood pressure and heart rate, while modestly decreasing food intake. These studies demonstrate that distinct melanocortin peptide drugs can have widely different efficacies and side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,924
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G. E., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,769
A frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159
A frameshift mutation in human MC4R is associated with a dominant form of obesity
Vaisse, C., Clément, K., Guy-grand, B., & Froguel, P. (1998) · Nature Genetics · doi:10.1038/2407 · Cited by 1,091
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates
McCurdy, C. E., Bishop, J. M., Williams, S., Grayson, B. E., Smith, M. S., Friedman, J. E., & Grove, K. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci32661 · Cited by 614
Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., & Cone, R. D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80829-6 · Cited by 612
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–230 of 230
Who are your scientific grandparents?
Miller, D. E. (2014) · Physiology News · doi:10.36866/pn.96.6a
Book review: Evolution of Obesity (Michael L Power and Jay Schulkin)
Arnold, J. T. (2014) · Physiology News · doi:10.36866/pn.96.43
Appetite control and exercise: not just energy-in and energy-out
Blundell, J. E. (2014) · Physiology News · doi:10.36866/pn.96.21
Adams, L. M. (2014) · Physiology News · doi:10.36866/pn.96.45
Melanocortin receptors in GtoPdb v.2021.3
Caruso, V., Chai, B., Clark, A., Cone, R. D., Eberlé, A. N., Farooqi, I. S., Fong, T. M., Gantz, I., Haskell‐Luevano, C., Hruby, V. J., et al. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f38/2021.3
(2014) · Physiology News · doi:10.36866/pn.96.8
Vestibular Nerve Stimulation as a Potential New Therapeutic Modality for Type 2 Diabetes MellitusPreprint
McGeoch, P. D., McKeown, J., & Kumar, S. S. (2020) · doi:10.31219/osf.io/4gxzr
Harper, R., Torrens, C., Kerin, J., Banks, R., & Patel, B. (2014) · Physiology News · doi:10.36866/pn.96.18
(2014) · Physiology News · doi:10.36866/pn.96.6
The Science of Life: How Your Body Works competition 2014
(2014) · Physiology News · doi:10.36866/pn.96.7
Daniels, D., & Mietlicki‐Baase, E. G. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734699055.793554621
Flannick, J. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735570136.793563021
Shukla, A. K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735570136.793559182
Amphetamine Acts Through the Melanocortin System to Regulate Metabolism and Cardiovascular FunctionPreprint
Simonds, S. E., Pryor, J. T., Lam, B., Dowsett, G. K. C., Mustafa, T., Munder, A. C., Elysee, K., Balland, É., Cowley, L. O., Yeo, G. S. H., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4088891
A INTELIGÊNCIA ARTIFICIAL E SUAS IMPLICAÇÕES NO CAMPO DA GENÉTICA
Neto, B. R. D. S. (2023) · doi:10.22533/at.ed.7932305011
OBESIDADE MONOGÊNICA NÃO SINDRÔMICA: DOS GENES À TERAPIA
Salum, K. C. R., Kohlrausch, F. B., & da Fonseca, A. C. P. (2023) · doi:10.22533/at.ed.7932305014
Guerra, A. P. C., & Gigonzac, T. C. V. (2023) · doi:10.22533/at.ed.7932305012
Genética: Molecular, humana e médica 3
Neto, B. R. D. S. (2023) · doi:10.22533/at.ed.793230501
O PAPEL DE SOCS3 EM DISTÚRBIOS METABÓLICOS NA HEPATITE C CRÔNICA: REVISÃO DA LITERATURA
Consuli, T. D. O., & Hoffmann, L. (2023) · doi:10.22533/at.ed.7932305013
PROTEINS AND PEPETIDES AS THERAPEUTICS
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets47886
Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy?
Kim, Y. J., Lim, J. H., & Kim, E. R. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111551
Choo, Y. N., Narayanan, R., & Subramaniyan, V. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107553 · Cited by 1
Review of medicines approved by the Food and Drug Administration from 2012 to 2024
Kurkin, D. V., Osadchenko, N. A., Bakulin, D. A., Morkovin, E. I., Voskresenskiy, S. A., Maltsev, D. V., Maltseva, M. O., Gorbunova, Y. V., Marincheva, O. V., Zvereva, V. I., et al. (2025) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2025-13-6-432-486
Özbay, B., Jülke, E., List, M., Nowicki, M., Els‐Heindl, S., Immig, K., Mörl, K., Bechmann, I., & Beck‐Sickinger, A. G. (2026) · Brain Communications · doi:10.1093/braincomms/fcaf450
Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors
Yue, W. K., Barlow, Ν., & Thompson, P. E. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00115g
Rationale of renewed efforts in developing MC4R modulators to treat metabolic disorders
Feng, W., Zhou, Q., & Wang, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.035
Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Hall, J. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Wang, Z., & Hall, M. E. (2026) · Clinical Science · doi:10.1042/cs20250039
Tao, Y., & Ji, R. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112876
Lee, C.-M., Kim, J.-Y., Shim, J.-H., & Cho, G.-W. (2026) · Hormone and Metabolic Research · doi:10.1055/a-2928-5204
Metadata
- Authors
- Kievit, P., Halem, H., Marks, D. L., Dong, J. Z., Glavas, M. M., Sinnayah, P., Pranger, L., Cowley, M. A., Grove, K. L., & Culler, M. D.
- Affiliations
- Oregon National Primate Research Center (US)
- Ipsen (United States) (US)
- Oregon Health & Science University (US)
- Corresponding author
- Grove, Kevin L.
- Culler, Michael D.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-01-17
- Volume
- 62
- Issue
- 2
- Pages
- 490-497
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3554387
- OpenAlex
- W2167727277
- Cited by
- 231
- References
- 45
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 16 · 2022: 15 · 2021: 22 · 2020: 14 · 2019: 17 · 2018: 18 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 36 · 2013: 8
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (OD 011092-53, P51OD011092)
- National Center for Research Resources (P51RR000163)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- melanocortin-4 receptor, MC4R agonist, diet-induced obesity, rhesus monkeys, weight loss, insulin resistance, glucose tolerance, cardiovascular function, blood pressure, heart rate, dietary intake, obesity pharmacotherapy, adverse drug reactions
- MeSH terms
- alpha-MSH, Animals, Blood Pressure, Cardiovascular System, Chronic Disease, Eating, Heart Rate, Insulin Resistance, Macaca mulatta, Male, Obesity, Peptides, Weight Loss, Glucose Intolerance, Anti-Obesity Agents, Receptor, Melanocortin, Type 4, Adiposity, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
